Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6183389rdf:typepubmed:Citationlld:pubmed
pubmed-article:6183389lifeskim:mentionsumls-concept:C0221102lld:lifeskim
pubmed-article:6183389lifeskim:mentionsumls-concept:C1524119lld:lifeskim
pubmed-article:6183389lifeskim:mentionsumls-concept:C0001057lld:lifeskim
pubmed-article:6183389lifeskim:mentionsumls-concept:C1521750lld:lifeskim
pubmed-article:6183389lifeskim:mentionsumls-concept:C1705294lld:lifeskim
pubmed-article:6183389pubmed:issue9lld:pubmed
pubmed-article:6183389pubmed:dateCreated1983-1-7lld:pubmed
pubmed-article:6183389pubmed:abstractTextThe urinary excretion of alanine aminopeptidase (EC 3.4.11.2) and N-acetyl-beta-D-glucosaminidase (EC 3.2.1.30) was determined in 23 patients with testicular cancer during sequential combination chemotherapy with vinblastine/bleomycin and doxorubicin/cis-platinum. Increases in enzyme excretion were more often noticed during therapy with vinblastine/bleomycin than with doxorubicin/cis-platinum. Moreover, the rises during vinblastine/bleomycin therapy were more pronounced. The enzyme activities varied from the normal range up to the 14-fold of the upper limit of the normal range. With few exceptions, enzyme excretions returned to normal or slightly elevated values before the subsequent course. No renal insufficiency could be detected with the commonly used parameters of renal function such as serum creatinine concentrations and creatinine clearance values, which were determined at irregular intervals.lld:pubmed
pubmed-article:6183389pubmed:languageenglld:pubmed
pubmed-article:6183389pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6183389pubmed:citationSubsetIMlld:pubmed
pubmed-article:6183389pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6183389pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6183389pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6183389pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6183389pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6183389pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6183389pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6183389pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6183389pubmed:statusMEDLINElld:pubmed
pubmed-article:6183389pubmed:monthSeplld:pubmed
pubmed-article:6183389pubmed:issn0340-076Xlld:pubmed
pubmed-article:6183389pubmed:authorpubmed-author:KnollEElld:pubmed
pubmed-article:6183389pubmed:authorpubmed-author:WisserHHlld:pubmed
pubmed-article:6183389pubmed:authorpubmed-author:LangerBBlld:pubmed
pubmed-article:6183389pubmed:authorpubmed-author:RatgeDDlld:pubmed
pubmed-article:6183389pubmed:authorpubmed-author:DienerUUlld:pubmed
pubmed-article:6183389pubmed:issnTypePrintlld:pubmed
pubmed-article:6183389pubmed:volume20lld:pubmed
pubmed-article:6183389pubmed:ownerNLMlld:pubmed
pubmed-article:6183389pubmed:authorsCompleteYlld:pubmed
pubmed-article:6183389pubmed:pagination615-9lld:pubmed
pubmed-article:6183389pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:6183389pubmed:meshHeadingpubmed-meshheading:6183389-...lld:pubmed
pubmed-article:6183389pubmed:meshHeadingpubmed-meshheading:6183389-...lld:pubmed
pubmed-article:6183389pubmed:meshHeadingpubmed-meshheading:6183389-...lld:pubmed
pubmed-article:6183389pubmed:meshHeadingpubmed-meshheading:6183389-...lld:pubmed
pubmed-article:6183389pubmed:meshHeadingpubmed-meshheading:6183389-...lld:pubmed
pubmed-article:6183389pubmed:meshHeadingpubmed-meshheading:6183389-...lld:pubmed
pubmed-article:6183389pubmed:meshHeadingpubmed-meshheading:6183389-...lld:pubmed
pubmed-article:6183389pubmed:meshHeadingpubmed-meshheading:6183389-...lld:pubmed
pubmed-article:6183389pubmed:meshHeadingpubmed-meshheading:6183389-...lld:pubmed
pubmed-article:6183389pubmed:meshHeadingpubmed-meshheading:6183389-...lld:pubmed
pubmed-article:6183389pubmed:meshHeadingpubmed-meshheading:6183389-...lld:pubmed
pubmed-article:6183389pubmed:meshHeadingpubmed-meshheading:6183389-...lld:pubmed
pubmed-article:6183389pubmed:meshHeadingpubmed-meshheading:6183389-...lld:pubmed
pubmed-article:6183389pubmed:meshHeadingpubmed-meshheading:6183389-...lld:pubmed
pubmed-article:6183389pubmed:meshHeadingpubmed-meshheading:6183389-...lld:pubmed
pubmed-article:6183389pubmed:meshHeadingpubmed-meshheading:6183389-...lld:pubmed
pubmed-article:6183389pubmed:meshHeadingpubmed-meshheading:6183389-...lld:pubmed
pubmed-article:6183389pubmed:meshHeadingpubmed-meshheading:6183389-...lld:pubmed
pubmed-article:6183389pubmed:year1982lld:pubmed
pubmed-article:6183389pubmed:articleTitleUrinary excretion of alanine-aminopeptidase and N-acetyl-beta-D-glucosaminidase during sequential combination chemotherapy.lld:pubmed
pubmed-article:6183389pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6183389pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed